Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102475 | 0.71 | TSHR (0.30) | — | |
| SCHEMBL15415721 | 0.66 | NPC1 (0.34) | — | |
| SCHEMBL7106608 | 0.65 | — | — | |
| SCHEMBL820008 | 0.60 | — | — | |
| SCHEMBL10335366 | 0.60 | — | — | |
| Hydrochloric Acid SCHEMBL16752783 | 0.58 | — | — | |
| SCHEMBL821436 | 0.58 | — | — | |
| SCHEMBL6678007 | 0.58 | — | — | |
| SCHEMBL8922960 | 0.58 | TSHR (0.44) | POLB | |
| SCHEMBL892513 | 0.58 | TSHR (0.44) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11019825-B2 | Product | ALPHA BIOPESTICIDES LIMITED (GB) | 2021-06-01 | — | — | US | disclosed |
| US-20180146683-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180146683-A1 | NEW PRODUCT | CYP51A1, ERG28, FASN | POLB 2408/4885 |
| US-11019825-B2 | Product | ERG28, FASN, CYP51A1 | POLB 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.